Assessing the Economic Implications of Broader Medicare Coverage for GLP-1 Receptor Agonists in Obesity Treatment
In recent years, the advent of glucagon-like peptide-1 receptor agonists (GLP-1RAs) has transformed therapeutic approaches to obesity, ushering in a ...
